Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;21(4):399-403.
doi: 10.1111/ddg.15034.

Developments and perspectives in allergology

Regina Treudler  1   2 , Jan-Christoph Simon  1   2
Affiliations
Review

Developments and perspectives in allergology

Regina Treudler et al. J Dtsch Dermatol Ges. 2023 Apr.

Abstract

Allergology is a key part of dermatological care. This paper reviews current pathophysiological, diagnostic and therapeutic developments in immediate-type allergies. Type-2 inflammation is involved in several allergological diseases such as allergic rhinitis and asthma. Allergen immunotherapy as an important therapeutic procedure is regulated in Germany by an official legal directive (Therapieallergene-Verordnung). Therapeutically, several biologics are already available that target interleukin (IL)-4, -5, -13, -33, or TSLP (thymic stromal lymphopoietin). Collateral efficacy may result in simultaneous treatment of allergological comorbidities. In mast cell mediated diseases (urticaria, anaphylaxis), there is increasing understanding of mast cell activation pathways. Several mast cell receptors such as MRGPRX2 (mas-related G protein coupled receptor X2) and Siglec-8 (sialinic acid binding Ig like lectin-8) as well as intracellular signaling pathways have recently been identified. Clinical trials are underway with drugs acting on mast cell receptors and intracellular signaling, i.e., Bruton's tyrosine kinase inhibitors. Further perspectives on biomarkers, novel therapeutics and unmet needs for future research activities are presented.

Keywords: allergy; biologicals; mast cell; review; therapy; type-2 inflammation.

PubMed Disclaimer

References

REFERENCES

    1. Augustin M, Franzke N, Beikert FC, et al. Allergies in Germany - prevalence and perception by the public. J Dtsch Dermatol Ges. 2013;11(6):514-520.
    1. Traidl-Hoffmann C, Treudler R, Pryzbilla B, et al. Die Arbeitsgemeinschaft Allergologie in der DDG. J Dtsch Dermatol Ges. 2014;12(Suppl 4):46-48.
    1. Garcovich S, Maurelli M, Gisondi P, et al. Pruritus as a distinctive feature of type 2 inflammation. Vaccines (Basel). 2021;23;9(3):303.
    1. Levi-Schaffer F, Gibbs BF, Hallgren J, et al. Selected recent advances in understanding the role of human mast cells in health and disease. J Allergy Clin Immunol. 2022;149(6):1833-1844.
    1. Al Hamwi G, Riedel YK, Clemens S, et al. MAS-related G protein-coupled receptors X (MRGPRX): Orphan GPCRs with potential as targets for future drugs. Pharmacol Ther. 2022;238:108259.

Publication types

LinkOut - more resources